The closing of the Offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be ...

Volcon, Inc. (NASDAQ:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to ...

Volcon (VLCN) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the company expected to be ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), a company engaged in developing drug delivery systems for pain management, announced the pricing of its public offering at $0.20 per share of ...

The Capital Market Authority (CMA) approved Saudi Economic and Development Securities Co.’s (SEDCO) request for the public ...

today announced the pricing of a best-efforts public offering of 762,500 common shares at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting ...

In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.

Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...